Safety and Efficacy of the Effect of Isosorbide Mononitrate in Reducing Pain During Levonorgestrel-releasing Intrauterine Device Insertion
NCT ID: NCT04311658
Last Updated: 2020-03-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
88 participants
INTERVENTIONAL
2020-03-30
2020-07-05
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
the Effect of Vitamin B 1 on Menstrual Pattern After Insertion of the IUD.
NCT05971680
Mirena Post-marketing Surveillance in Japan
NCT01414140
Prospective, Non-interventional, Multi-center Safety Study of Mirena for Heavy Menstrual Bleeding and Dysmenorrhea
NCT02475356
Maintaining Intrauterine Devices (IUDs) in Teens (MINT): A Randomization Trial
NCT00653159
3 mL Inhaled Methoxyflurane for Intrauterine Device (IUD) Insertion
NCT07295054
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Isosorbide Mononitrate
one tablet of Isosorbide Mononitrate (40 mg) vaginally 3 hours prior to LNG-IUD insertion
Isosorbide Mononitrate 40 MG
one tablet of Isosorbide Mononitrate (40 mg) vaginally 3 hours prior to LNG- IUD insertion
placebo
one tablet of placebo vaginally 3 hours prior to LNG- IUD insertion
Placebo
one tablet of placebo vaginally 3 hours prior to LNG-IUD insertion
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Isosorbide Mononitrate 40 MG
one tablet of Isosorbide Mononitrate (40 mg) vaginally 3 hours prior to LNG- IUD insertion
Placebo
one tablet of placebo vaginally 3 hours prior to LNG-IUD insertion
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
14 Years
25 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ahmed Samy aly ashour
assistant professor obstetrics and gynecology
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
isosorbide mononitrate IUDs
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.